Literature DB >> 15774549

2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.

Barbara L F Kaplan1, Yanli Ouyang, Cheryl E Rockwell, Gautham K Rao, Norbert E Kaminski.   

Abstract

2-Arachidonoyl-glycerol (2-AG), an endogenous ligand for cannabinoid receptor types 1 and 2 (CB1 and CB2), has previously been demonstrated to modulate immune functions including suppression of interleukin-2 expression and nuclear factor of activated T cells (NFAT) activity. The objective of the present studies was to investigate the effect of 2-AG on interferon-gamma (IFN-gamma) expression and associated upstream signaling events. Pretreatment of splenocytes with 2-AG markedly suppressed phorbol 12-myristate 13-acetate plus calcium ionophore (PMA/Io)-induced IFN-gamma secretion. In addition, 2-AG suppressed IFN-gamma steady-state mRNA expression in a concentration-dependent manner. To unequivocally determine the putative involvement of CB1 and CB2, splenocytes derived from CB1(-/-)/CB2(-/-) knockout mice were used. No difference in the magnitude of IFN-gamma suppression by 2-AG in wild-type versus CB1/CB2 null mice was observed. Time-of-addition studies revealed that 2-AG treatment up to 12 h post-cellular activation resulted in suppression of IFN-gamma, which was consistent with a time course conducted with cyclosporin A, an inhibitor of NFAT activity. Coincidentally, 2-AG perturbed the nuclear translocation of NFAT protein and blocked thapsigargin-induced elevation in intracellular calcium, suggesting that altered calcium regulation might partly explain the suppression of NFAT nuclear translocation and subsequent IFN-gamma production. Indeed, Io partially attenuated the 2-AG-induced suppression of PMA/Io-stimulated IFN-gamma production. Taken together, these data demonstrate that 2-AG suppresses IFN-gamma expression in murine splenocytes in a CB receptor-independent manner and that the mechanism partially involves suppression of intracellular calcium signaling and perturbation of NFAT nuclear translocation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774549     DOI: 10.1189/jlb.1104652

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

Review 2.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

3.  An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.

Authors:  C R Hutch; C J Hillard; C Jia; C C Hegg
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 4.  Do cannabinoids have a therapeutic role in transplantation?

Authors:  Mitzi Nagarkatti; Sadiye Amcaoglu Rieder; Venkatesh L Hegde; Shunsuke Kanada; Prakash Nagarkatti
Journal:  Trends Pharmacol Sci       Date:  2010-06-28       Impact factor: 14.819

Review 5.  The peripheral cannabinoid receptor knockout mice: an update.

Authors:  N E Buckley
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 6.  Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.

Authors:  C A Lunn; E-P Reich; J S Fine; B Lavey; J A Kozlowski; R W Hipkin; D J Lundell; L Bober
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

7.  The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).

Authors:  Barbara L F Kaplan; Alison E B Springs; Norbert E Kaminski
Journal:  Biochem Pharmacol       Date:  2008-07-08       Impact factor: 5.858

Review 8.  Cannabinoids, endocannabinoids, and related analogs in inflammation.

Authors:  Sumner H Burstein; Robert B Zurier
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

9.  Development and utilization of a custom PCR array workflow: analysis of gene expression in mycoplasma genitalium and guinea pig (Cavia porcellus).

Authors:  Ronald L Veselenak; Aaron L Miller; Gregg N Milligan; Nigel Bourne; Richard B Pyles
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

Review 10.  Neuroimmunity, drugs of abuse, and neuroAIDS.

Authors:  Tricia H Burdo; Simon N Katner; Michael A Taffe; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.